DexCom, Inc. vs Quest Diagnostics Incorporated
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- DexCom, Inc. is the larger company by market value: $29.9 B against $27.8 B for Quest Diagnostics Incorporated, 1.1 times as much (market caps of Oct 22, 2026 for DexCom, Inc. and Oct 30, 2026 for Quest Diagnostics Incorporated).
- Quest Diagnostics Incorporated had more revenue: $11.0 B against $4.7 B for DexCom, Inc., both in the year to December 2025.
- Quest Diagnostics Incorporated earned more: net income of $992 M against $836 M for DexCom, Inc.
- DexCom, Inc. keeps more of each dollar of sales: a net margin of 17.9% against 9.0% for Quest Diagnostics Incorporated.
- Quest Diagnostics Incorporated employs more people: 57,000 against 11,100 at DexCom, Inc. Each employee brings in about $420,000 of revenue at DexCom, Inc. and $193,596 at Quest Diagnostics Incorporated.
- On price to earnings, DexCom, Inc. trades at 30.2× and Quest Diagnostics Incorporated at 24.6×: investors pay more for each dollar of DexCom, Inc.'s profit.
- DexCom, Inc.'s revenue grew faster in its latest fiscal year: +15.6% against +11.8% for Quest Diagnostics Incorporated.
- Both are in the safe zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | DexCom, Inc. DXCM · #854 in the world | Quest Diagnostics Incorporated DGX · #902 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1999 | 1967 |
| Size | ||
| Market cap | $29.9 B | $27.8 B |
| Revenue | $4.7 B | $11.0 B |
| Net income | $836 M | $992 M▲ best |
| Employees | 11,100 | 57,000 |
| Valuation | ||
| P/E ratio | 30.2× | 24.6× |
| Price to sales | 5.9× | 2.4× |
| Price to book | 10.9× | 3.9× |
| Free cash flow yield | 3.6% | 4.9%▲ best |
| Profitability | ||
| Gross margin | 60.1%▲ best | 33.2% |
| Operating margin | 19.6%▲ best | 14.1% |
| Net margin | 17.9%▲ best | 9.0% |
| Return on equity | 34.5%▲ best | 14.2% |
| Return on invested capital | — | 9.5% |
| Growth | ||
| Revenue growth | 15.6%▲ best | 11.8% |
| Revenue growth, 3 years a year | 17.0%▲ best | 3.7% |
| Earnings per share growth | 47.2%▲ best | 13.8% |
| Financial strength | ||
| Debt to equity | — | 0.8× |
| Net debt to EBITDA | — | 2.5× |
| Interest cover | 63.8× | — |
| Cash | ||
| Free cash flow margin | 23.1%▲ best | 12.3% |
| Shareholder returns | ||
| Dividend yield | — | 1.3% |
| Shareholder yield | 1.7% | 2.9%▲ best |
| Strength scores | ||
| Piotroski F-score | — | 8 of 9 |
| Altman Z-score zone | safe | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, DexCom, Inc. or Quest Diagnostics Incorporated?
DexCom, Inc. is the larger company by market value: $29.9 B against $27.8 B for Quest Diagnostics Incorporated, 1.1 times as much (market caps of Oct 22, 2026 for DexCom, Inc. and Oct 30, 2026 for Quest Diagnostics Incorporated).
Which makes more money, DexCom, Inc. or Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated had more revenue: $11.0 B against $4.7 B for DexCom, Inc., both in the year to December 2025. Quest Diagnostics Incorporated earned more: net income of $992 M against $836 M for DexCom, Inc.
Which is more profitable, DexCom, Inc. or Quest Diagnostics Incorporated?
DexCom, Inc. keeps more of each dollar of sales: a net margin of 17.9% against 9.0% for Quest Diagnostics Incorporated.
Which has more employees, DexCom, Inc. or Quest Diagnostics Incorporated?
Quest Diagnostics Incorporated employs more people: 57,000 against 11,100 at DexCom, Inc. Each employee brings in about $420,000 of revenue at DexCom, Inc. and $193,596 at Quest Diagnostics Incorporated.
Is DexCom, Inc. cheaper than Quest Diagnostics Incorporated?
On price to earnings, DexCom, Inc. trades at 30.2× and Quest Diagnostics Incorporated at 24.6×: investors pay more for each dollar of DexCom, Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, DexCom, Inc. or Quest Diagnostics Incorporated?
DexCom, Inc.'s revenue grew faster in its latest fiscal year: +15.6% against +11.8% for Quest Diagnostics Incorporated.
Which is financially stronger, DexCom, Inc. or Quest Diagnostics Incorporated?
Both are in the safe zone of the Altman Z-score.
More about DexCom, Inc.
More about Quest Diagnostics Incorporated
- Quest Diagnostics Incorporated: company page
- Who owns Quest Diagnostics Incorporated?
- Quest Diagnostics Incorporated market cap history
- Quest Diagnostics Incorporated revenue by year
- How many employees does Quest Diagnostics Incorporated have?
- Is Quest Diagnostics Incorporated cheap or expensive?
- Quest Diagnostics Incorporated against its peers: ranks and percentiles
Sources#
Every figure on this page comes from these, with the date shown next to it.